TRPC channels as emerging targets for seizure disorders

Area of Science:

• Neuroscience
• Pharmacology
• Channelopathies

Background:

• Epilepsy affects 1-2% of the global population with diverse seizure types.
• Existing antiseizure medications offer symptomatic relief but are often ineffective or cause adverse effects in a significant portion of patients.
• Transient receptor potential canonical (TRPC) channels are nonselective cation channels with diverse physiological roles.

Purpose of the Study:

• To review preclinical evidence on the role of TRPC channels in epilepsy.
• To explore TRPC channels as potential therapeutic targets for epilepsy.
• To advance the development of novel antiseizure and antiepileptogenic therapies.

Main Methods:

• Review of recent preclinical studies.
• Analysis of genetic strategies targeting TRPC channels.
• Evaluation of pharmacological approaches involving TRPC channels.

Main Results:

• Preclinical studies indicate TRPC channels play fundamental roles in epileptic seizures.
• Receptor-operated, calcium-permeable TRPC channels are implicated in seizure pathophysiology.
• Evidence suggests TRPC channels are viable targets for therapeutic intervention.

Conclusions:

• TRPC channels represent promising therapeutic targets for epilepsy.
• Targeting TRPC channels could lead to new antiseizure and antiepileptogenic treatments.
• Further research into TRPC channel function may unlock novel epilepsy therapies.